Aurinia Pharmaceuticals (AUPH) EBITDA Margin (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) recorded EBITDA Margin of 61.49% in Q2 2026, up 25.86 percentage points from 35.63% a year earlier and up 1.99 percentage points from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) EBITDA Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Aurinia Pharmaceuticals' EBITDA Margin came in at 54.61% as of Jun 30, 2026, up 27.13 percentage points year-over-year; for FY2025, it was 43.94%, up 37.66 percentage points from FY2024.
- Annual EBITDA Margin has increased for four straight years, with a five-year change of +247.05 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 6.28% in FY2024 (+51.88 pp), -45.61% in FY2023 (+35.54 pp), -81.15% in FY2022 (+304.50 pp) and -385.65% in FY2021 (-182.53 pp).
- The Q2 2026 figure is the highest quarterly EBITDA Margin in data going back to Q1 2020.
- On a year-over-year basis, EBITDA Margin has increased for 11 consecutive quarters, with an average year-over-year change of +40.99 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 144485.72 percentage points in Q3 2021, against a drop of 128.11 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 59.50% (Q1 2026), 49.41% (Q4 2025) and 47.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Aurinia Pharmaceuticals | 2.20 Bn | 623.91 Mn | 76.67 Mn | 61.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.49% |
| Mar 31, 2026 | 59.50% |
| Dec 31, 2025 | 49.41% |
| Sep 30, 2025 | 47.11% |
| Jun 30, 2025 | 35.63% |
| Mar 31, 2025 | 42.75% |
| Dec 31, 2024 | 5.33% |
| Sep 30, 2024 | 24.55% |
| Jun 30, 2024 | 5.82% |
| Mar 31, 2024 | -16.71% |
| Dec 31, 2023 | -79.33% |
| Sep 30, 2023 | -20.18% |
| Jun 30, 2023 | -37.24% |
| Mar 31, 2023 | -83.89% |
| Dec 31, 2022 | -105.46% |
| Sep 30, 2022 | -15.03% |
| Jun 30, 2022 | -125.22% |
| Mar 31, 2022 | -172.00% |
| Dec 31, 2021 | -143.45% |
| Sep 30, 2021 | -338.42% |
API Access
Aurinia Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();